Works matching IS 02704137 AND DT 2010 AND VI 70 AND IP 6

Results: 11

The impact of HMG-CoA reductase therapy on serum PSA.

Published in:

Prostate, 2010, v. 70, n. 6, p. 608, doi. 10.1002/pros.21095

By:

Mener, David J.;
Cambio, Angelo;
Stoddard, David G.;
Martin, Brad A.;
Palapattu, Ganesh S.

Publication type:

Article

Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.

Published in:

Prostate, 2010, v. 70, n. 6, p. 591, doi. 10.1002/pros.21093

By:

Nandana, Srinivas;
Ellwood-Yen, Katharine;
Sawyers, Charles;
Wills, Marcia;
Weidow, Brandy;
Case, Thomas;
Vasioukhin, Valeri;
Matusik, Robert

Publication type:

Article

HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.

Published in:

Prostate, 2010, v. 70, n. 6, p. 601, doi. 10.1002/pros.21094

By:

Stevens, Victoria L.;
Ahn, Jiyoung;
Sun, Juzhong;
Jacobs, Eric J.;
Moore, Steven C.;
Patel, Alpa V.;
Berndt, Sonja I.;
Albanes, Demetrius;
Hayes, Richard B.

Publication type:

Article

Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.

Published in:

Prostate, 2010, v. 70, n. 6, p. 646, doi. 10.1002/pros.21098

By:

Lubahn, Jessica;
Berndt, Sonja I.;
Jin, Carol H.;
Klim, Aleksandra;
Luly, Jason;
Wu, William S.;
Isaacs, Sarah;
Wiley, Kathleen;
Isaacs, William B.;
Suarez, Brian K.;
Hayes, Richard B.;
Kibel, Adam S.

Publication type:

Article

Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines.

Published in:

Prostate, 2010, v. 70, n. 6, p. 675, doi. 10.1002/pros.21112

By:

Karanikolas, Breanne D.W.;
Figueiredo, Marxa L.;
Wu, Lily

Publication type:

Article

POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma.

Published in:

Prostate, 2010, v. 70, n. 6, p. 666, doi. 10.1002/pros.21100

By:

Kastler, Silvia;
Honold, Lisa;
Luedeke, Manuel;
Kuefer, Rainer;
Möller, Peter;
Hoegel, Josef;
Vogel, Walther;
Maier, Christiane;
Assum, Guenter

Publication type:

Article

Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial.

Published in:

Prostate, 2010, v. 70, n. 6, p. 584, doi. 10.1002/pros.21092

By:

Kristal, Alan R.;
Price, Douglas K.;
Till, Cathee;
Schenk, Jeannette M.;
Neuhouser, Marian L.;
Ockers, Sandy;
Lin, Daniel W.;
Thompson, Ian M.;
Figg, William D.

Publication type:

Article

Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.

Published in:

Prostate, 2010, v. 70, n. 6, p. 616, doi. 10.1002/pros.21096

By:

Li, Yingming;
Malaeb, Bahaa S.;
Li, Zhong-ze;
Thompson, Melissa G.;
Chen, Zhi;
Corey, David R.;
Hsieh, Jer-Tsong;
Shay, Jerry W.;
Koeneman, Kenneth S.

Publication type:

Article

Downmodulation of Bcl-2 sensitizes metastatic LNCaP-LN3 cells to undergo apoptosis via the intrinsic pathway.

Published in:

Prostate, 2010, v. 70, n. 6, p. 571, doi. 10.1002/pros.21091

By:

Song, Renduo;
Harris, Loleta D.;
Pettaway, Curtis A.

Publication type:

Article

Molecular characterization of the Gγ-globin-Tag transgenic mouse model of hormone refractory prostate cancer: Comparison to human prostate cancer.

Published in:

Prostate, 2010, v. 70, n. 6, p. 630, doi. 10.1002/pros.21097

By:

Calvo, Alfonso;
Perez-Stable, Carlos;
Segura, Victor;
Catena, Raúl;
Guruceaga, Elizabeth;
Nguewa, Paul;
Blanco, David;
Parada, Luis;
Reiner, Teresita;
Green, Jeffrey E.

Publication type:

Article

The developmental expression profile of PAX2 in the murine prostate.

Published in:

Prostate, 2010, v. 70, n. 6, p. 654, doi. 10.1002/pros.21099

By:

Chen, Qian;
DeGraff, David J.;
Sikes, Robert A.

Publication type:

Article